Market Closed -
Other stock markets
|
After market 23:24:09 | |||
141.1 USD | +0.06% | 141.6 | +0.32% |
05-02 | Ascendis Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-02 | Earnings Flash (ASND) ASCENDIS PHARMA Reports Q1 Revenue EUR95.9M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.03% | 8.06B | |
-1.65% | 103B | |
+6.75% | 101B | |
+5.71% | 23.07B | |
-12.60% | 22.23B | |
-9.70% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- ASND Stock
- News Ascendis Pharma A/S
- Ascendis Pharma A/S : Canaccord Adjusts Ascendis Pharma A/S' Price Target to $190 from $172, Keeps Buy Rating